Modulation of the immune system by melatonin; implications for cancer therapy
M Moslehi, R Moazamiyanfar, MS Dakkali… - International …, 2022 - Elsevier
Immune system interactions within the tumour have a key role in the resistance or
sensitization of cancer cells to anti-cancer agents. On the other hand, activation of the …
sensitization of cancer cells to anti-cancer agents. On the other hand, activation of the …
[HTML][HTML] Exploring the molecular tumor microenvironment and translational biomarkers in brain metastases of non-small-cell lung cancer
J Wen, JZ Yu, C Liu, AAO Ould Ismail… - International Journal of …, 2024 - mdpi.com
Brain metastases represent a significant clinical challenge in the treatment of non-small-cell
lung cancer (NSCLC), often leading to a severe decline in patient prognosis and survival …
lung cancer (NSCLC), often leading to a severe decline in patient prognosis and survival …
[HTML][HTML] Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry
W Ma, S Wei, S Long, EC Tian, B McLaughlin… - Frontiers in …, 2023 - frontiersin.org
Introduction Immune checkpoint inhibitors (ICIs) only benefit a subset of cancer patients,
underlining the need for predictive biomarkers for patient selection. Given the limitations of …
underlining the need for predictive biomarkers for patient selection. Given the limitations of …
[HTML][HTML] Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors
RB Young, H Panchal, W Ma, S Chen, A Steele… - Frontiers in …, 2022 - frontiersin.org
Background Immune checkpoint inhibitor (ICI) therapy has improved survivals with a
favorable toxicity profile in a variety of cancer patients. We hypothesized that hospitalized …
favorable toxicity profile in a variety of cancer patients. We hypothesized that hospitalized …
Xin Li1†, Chunqiu Xia1†, Minghui Liu1†, Jinghao Liu1, Ming Dong1, Honglin Zhao1, Song Xu1, Dan Wang2, Sen Wei1
Z Song, G Chen, H Liu, J Chen - Optimizing Outcomes and …, 2023 - books.google.com
Neoadjuvant therapy is one of the many approaches to locally advanced non-small cell lung
cancer (NSCLC)(1). However, traditional platinum-based chemotherapy either before or …
cancer (NSCLC)(1). However, traditional platinum-based chemotherapy either before or …